Work at Summittherapeutics.

Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on discovering, developing, and commercializing therapies for serious unmet medical needs. Its lead program is ivonescimab, a bispecific antibody being advanced for solid tumor indications,...

Healthcare Biotechnology Health Care Medical Device Therapeutics

Open roles 6

Founded 2003

Type Public · SMMT

Team size 201–500

Headquarters Palo Alto

Website smmttx.com

Legal name Summit Therapeutics Inc.

View on LinkedIn →

Open roles at Summittherapeutics

6 open roles

Director, Portfolio Strategy United States of America · United States of America Salary TBC 9 days ago

Associate Director, Site Alliances and Strategy United Kingdom · United Kingdom Salary TBC 24 days ago

Director, Clinical Operations Analytics & Performance Excellence United Kingdom · United Kingdom Salary TBC 31 days ago

Sr. Clinical Data Scientist Palo Alto · Palo Alto $148,000–$188,000 / year 59 days ago

Senior Manager, Commercial Analytics Princeton · Princeton $150,000–$170,000 / year 65 days ago

Senior Director, Regional Marketing Princeton · Princeton $220,000–$270,000 / year 65 days ago

About Summittherapeutics

Products & services

Ivonescimab (SMT112; AK112) An investigational bispecific antibody for oncology that targets PD-1 and VEGF in a single molecule. It is being studied primarily in non-small cell lung cancer and other solid tumors.

Leadership

Robert Duggan Chief Executive Officer
Ankur Dhingra Chief Financial Officer
Robert LaCaze Chief Commercial Officer
Manmeet Soni Chief Operating Officer and Chief Financial Officer
Dame Davies Founder

Seniority mix

Entry & junior 0 roles
Mid-level 0 roles
Senior 2 roles
Lead & principal 0 roles
Manager & above 5 roles

Based on 7 open roles

Work at Summittherapeutics.

Open roles at Summittherapeutics

Subscribe to Career Resources.

Your cookie choices